Literature DB >> 3552350

Myelodysplastic syndromes: natural history and features of prognostic importance.

G J Mufti, D A Galton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3552350

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


× No keyword cloud information.
  14 in total

Review 1.  Myelodysplastic syndromes.

Authors:  I M Hann
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

2.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population.

Authors:  Dragomir Marisavljević; Nada Kraguljac; Zoran Rolović
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 4.  Infections in myelodysplastic syndromes.

Authors:  Andréa Toma; Pierre Fenaux; François Dreyfus; Catherine Cordonnier
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

Review 5.  The myelodysplastic syndromes.

Authors:  D M Layton; G J Mufti
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-25

Review 6.  Biology and treatment of myelodysplastic syndromes--developments in the past decade.

Authors:  R Willemze; W E Fibbe; J H Falkenburg; J C Kluin-Nelemans; P M Kluin; J E Landegent
Journal:  Ann Hematol       Date:  1993-03       Impact factor: 3.673

7.  Comparison of 2 preparative regimens for stem cell transplantation from HLA-matched sibling donors in patients with advanced myelodysplastic syndrome.

Authors:  Yoo-Jin Kim; Dong-Wook Kim; Seok Lee; Chang-Ki Min; Dong-Gun Lee; Soo-Mi Choi; Ki-Seong Eom; Hee-Je Kim; Jong-Wook Lee; Woo-Sung Min; Chun-Choo Kim
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 8.  Identification and treatment of anaemia in older patients.

Authors:  P T Murphy; R M Hutchinson
Journal:  Drugs Aging       Date:  1994-02       Impact factor: 3.923

Review 9.  Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature.

Authors:  Norihide Sato; Tomonori Nakazato; Masahiro Kizaki; Yasuo Ikeda; Shinichiro Okamoto
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

10.  Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.

Authors:  Azra Raza; Naomi Galili; Natalie Callander; Leonel Ochoa; Lawrence Piro; Peter Emanuel; Stephanie Williams; Howard Burris; Stefan Faderl; Zeev Estrov; Peter Curtin; Richard A Larson; James G Keck; Marsha Jones; Lisa Meng; Gail L Brown
Journal:  J Hematol Oncol       Date:  2009-05-13       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.